Last updated: 13 November 2023 at 2:54pm EST

M Michelle Berrey Net Worth




The estimated Net Worth of M Michelle Berrey is at least $1.89 Milion dollars as of 12 June 2018. M Berrey owns over 10,000 units of Intercept Pharmaceuticals Inc stock worth over $1,894,015 and over the last 11 years M sold ICPT stock worth over $0.

M Berrey ICPT stock SEC Form 4 insiders trading

M has made over 17 trades of the Intercept Pharmaceuticals Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently M bought 10,000 units of ICPT stock worth $45,000 on 12 June 2018.

The largest trade M's ever made was exercising 44,014 units of Intercept Pharmaceuticals Inc stock on 15 November 2013 worth over $187,500. On average, M trades about 6,012 units every 45 days since 2013. As of 12 June 2018 M still owns at least 99,685 units of Intercept Pharmaceuticals Inc stock.

You can see the complete history of M Berrey stock trades at the bottom of the page.



What's M Berrey's mailing address?

M's mailing address filed with the SEC is C/O INTERCEPT PHARMACEUTICALS, INC, 305 MADISON AVENUE, MORRISTOWN, NJ, 07960.

Insiders trading at Intercept Pharmaceuticals Inc

Over the last 12 years, insiders at Intercept Pharmaceuticals Inc have traded over $1,530,243,701 worth of Intercept Pharmaceuticals Inc stock and bought 2,408,920 units worth $77,118,364 . The most active insiders traders include Srinivas Akkaraju, Jonathan Silverstein a Francesco Micheli. On average, Intercept Pharmaceuticals Inc executives and independent directors trade stock every 10 days with the average trade being worth of $1,114,673. The most recent stock trade was executed by Srinivas Akkaraju on 10 March 2021, trading 237,000 units of ICPT stock currently worth $5,017,290.



What does Intercept Pharmaceuticals Inc do?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.



What does Intercept Pharmaceuticals Inc's logo look like?

Intercept Pharmaceuticals Inc logo

Complete history of M Berrey stock trades at Chimerix Inc a Intercept Pharmaceuticals Inc

Datum
#
Společnost
Osoba
Trans.
Transakce
Počet akcií Cena za akcii Celková cena Počet akcií po Zdroj
12 Jun 2018 M Michelle Berrey
Prezident a CEO
Koupě 10,000 $4.50 $45,000
12 Jun 2018
99,685
8 May 2018 M Michelle Berrey
Prezident a CEO
Využití opce 11,250 $4.26 $47,925
8 May 2018
325,256
6 Mar 2018 M Michelle Berrey
Prezident a CEO
Využití opce 10,071 $4.26 $42,902
6 Mar 2018
311,336
21 Jun 2017 M Michelle Berrey
Prezident a CEO
Využití opce 23,474 $4.26 $99,999
21 Jun 2017
323,947
29 Nov 2016 M Michelle Berrey
Prezident a CEO
Využití opce 2,400 $4.26 $10,224
29 Nov 2016
288,161
29 Aug 2016 M Michelle Berrey
Prezident a CEO
Koupě 22,417 $4.47 $100,204
29 Aug 2016
281,238
24 Jun 2016 M Michelle Berrey
Prezident a CEO
Koupě 13,188 $3.69 $48,664
24 Jun 2016
258,821
1 Mar 2016 M Michelle Berrey
Prezident a CEO
Využití opce 11,001 $4.26 $46,864
1 Mar 2016
145,633
26 Aug 2015 M Michelle Berrey
Prezident a CEO
Využití opce 2,796 $18.75 $52,425
26 Aug 2015
133,434
20 Mar 2015 M Michelle Berrey
Prezident a CEO
Využití opce 12,926 $10.53 $136,111
20 Mar 2015
130,638
21 Jan 2015 M Michelle Berrey
Prezident a CEO
Využití opce 3,668 $4.26 $15,626
21 Jan 2015
116,282
22 Dec 2014 M Michelle Berrey
Prezident a CEO
Využití opce 14,672 $4.26 $62,503
22 Dec 2014
112,614
2 Sep 2014 M Michelle Berrey
Prezident a CEO
Využití opce 14,671 $4.26 $62,498
2 Sep 2014
97,942
27 May 2014 M Michelle Berrey
Prezident a CEO
Koupě 14,065 $14.22 $200,004
27 May 2014
83,271
21 May 2014 M Michelle Berrey
Prezident a CEO
Využití opce 18,330 $4.26 $78,086
21 May 2014
69,197
15 Nov 2013 M Michelle Berrey
Prezident a CEO
Využití opce 44,014 $4.26 $187,500
15 Nov 2013
49,554
23 Aug 2013 M Michelle Berrey
Prezident a CEO
Koupě 5,540 $18.70 $103,598
23 Aug 2013
5,540


Intercept Pharmaceuticals Inc executives and stock owners

Intercept Pharmaceuticals Inc executives and other stock owners filed with the SEC include: